As of 2026-03-13, the Relative Valuation of United Therapeutics Corp (UTHR) is 636.96 USD. This relative valuation is based on P/E multiples. With the latest stock price at 532.82 USD, the upside of United Therapeutics Corp based on Relative Valuation is 19.5%.
The range of the Relative Valuation is 568.47 - 718.82 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 22.2x | 20.0x |
| Forward P/E multiples | 18.3x - 22.2x | 20.2x |
| Fair Price | 568.47 - 718.82 | 636.96 |
| Upside | 6.7% - 34.9% | 19.5% |
| Date | P/E |
| 2026-03-12 | 17.19 |
| 2026-03-11 | 17.57 |
| 2026-03-10 | 17.29 |
| 2026-03-09 | 17.07 |
| 2026-03-06 | 15.43 |
| 2026-03-05 | 15.65 |
| 2026-03-04 | 15.82 |
| 2026-03-03 | 16.09 |
| 2026-03-02 | 16.58 |
| 2026-02-27 | 16.26 |
| 2026-02-26 | 16.25 |
| 2026-02-25 | 17.26 |
| 2026-02-24 | 15.27 |
| 2026-02-23 | 15.31 |
| 2026-02-20 | 15.27 |
| 2026-02-19 | 15.50 |
| 2026-02-18 | 15.36 |
| 2026-02-17 | 15.56 |
| 2026-02-13 | 15.28 |
| 2026-02-12 | 15.36 |
| 2026-02-11 | 15.35 |
| 2026-02-10 | 15.27 |
| 2026-02-09 | 15.26 |
| 2026-02-06 | 15.66 |
| 2026-02-05 | 15.45 |
| 2026-02-04 | 15.57 |
| 2026-02-03 | 15.43 |
| 2026-02-02 | 15.32 |
| 2026-01-30 | 15.15 |
| 2026-01-29 | 15.09 |
| 2026-01-28 | 15.08 |
| 2026-01-27 | 15.38 |
| 2026-01-26 | 15.27 |
| 2026-01-23 | 15.13 |
| 2026-01-22 | 15.23 |
| 2026-01-21 | 15.16 |
| 2026-01-20 | 15.10 |
| 2026-01-16 | 15.00 |
| 2026-01-15 | 15.23 |
| 2026-01-14 | 15.35 |
| 2026-01-13 | 15.38 |
| 2026-01-12 | 15.56 |
| 2026-01-09 | 15.59 |
| 2026-01-08 | 15.84 |
| 2026-01-07 | 16.25 |
| 2026-01-06 | 16.22 |
| 2026-01-05 | 15.80 |
| 2026-01-02 | 16.03 |
| 2025-12-31 | 15.72 |
| 2025-12-30 | 16.01 |